Riskpilot← Back to searchSign inGet full accessFARMASIET AS
ASActiveOrg 913379721Wergelandsveien 23, 0167 OsloRetail sale of pharmaceutical products · NACE 4773Est. 2014119 employees
Revenue 2024
NOK 778,2M
+30% vs 2023
EBITDA margin
-4.9%
+41% vs 2023
Equity ratio
-36.6%
Financial strength
Net profit 2024
NOK -58,7M
+22% vs 2023
| Revenue | NOK 778,2M | +30% |
| EBITDA | NOK -38,5M | +41% |
| Net profit | NOK -58,7M | +22% |
| Total assets | NOK 198,9M | -2% |
| Equity | NOK -72,8M | -407% |
| Employees | 119 | — |
Legal name
FARMASIET AS
Org number
913379721
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
17. mars 2014
Share capital
NOK 22 628 564
Employees
119 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. To styremedlemmer i fellesskap.
Company purpose
Apotekvirksomhet ved egne utsalgssteder og ved salg av apotekvarer via internett samt all virksomhet som står i forbindelse med dette, herunder det å eie aksjer i andre selskaper med samme formål eller selskaper i tilsvarende bransje.
Address
Wergelandsveien 23, 0167 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2 529 | 23 547 | 74 335 | 129 983 | 163 417 | 326 965 | 447 836 | 525 827 | 597 280 | 778 188 |
| Staff expenses | −0 | −8 | −12 890 | −16 060 | −20 195 | −17 708 | −27 677 | −45 517 | −49 297 | −56 522 | −70 261 |
| EBITDA | 0 | −542 | −26 531 | −33 802 | −25 274 | −36 456 | −98 707 | −60 390 | −72 935 | −64 917 | −38 461 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −1 941 | −18 496 | −5 959 | −2 740 | −2 447 | −4 781 | −11 137 |
| EBIT | 0 | −542 | −26 531 | −33 802 | −27 215 | −54 951 | −104 666 | −63 131 | −75 383 | −69 698 | −49 598 |
| Net financials | 35 | 143 | −81 | −418 | −372 | −360 | −979 | −457 | −3 655 | −5 847 | −9 060 |
| Profit before tax | 35 | −399 | −26 612 | −34 221 | −27 587 | −55 311 | −105 645 | −63 588 | −79 037 | −75 545 | −58 658 |
| Tax | 10 | −0 | −0 | −14 651 | −6 335 | −0 | −6 600 | −9 565 | −7 152 | −0 | −0 |
| Net profit | 26 | −399 | −26 612 | −19 569 | −21 252 | −55 311 | −99 045 | −54 023 | −71 885 | −75 545 | −58 658 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 423 | 10 522 | 12 545 | 75 578 | 74 729 | 53 723 | 94 882 | 109 856 | 178 223 | 203 943 | 198 932 |
| Equity | 8 330 | 7 931 | −18 681 | 8 145 | 8 103 | −10 737 | −16 999 | −2 033 | 13 514 | −14 346 | −72 798 |
| Long-term debt | 0 | 0 | 0 | 0 | 29 535 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 93 | 2 591 | 31 226 | 67 433 | 37 091 | 64 460 | 109 508 | 111 256 | 163 931 | 218 003 | 272 199 |
| Total debt | 93 | 2 591 | 31 226 | 67 433 | 66 626 | 64 460 | 109 508 | 111 256 | 163 931 | 218 003 | 272 199 |
EBITDA margin
-4.9%
This company
15.8%
Market median
-131% vs market
20142024
Equity ratio
-36.6%
This company
38.2%
Market median
-196% vs market
20142024
Return on equity
-5865800200.0%
This company
18.4%
Market median
-31879349013% vs market
20142024
Net profit margin
-7.5%
This company
8.1%
Market median
-193% vs market
20142024
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20142024
Debt / equity
3.73×
This company
0.62×
Market median
-502% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HA Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
NA Deputy Member | Deputy Member | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Verdane Capital X Cordelia Co-Inves | Company | 97.2% | 97.2% | 2024 |
| Individual | 80.3% | 80.3% | 2022 | |
Erupt Holding Ab | Company | 1.7% | 1.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FARMASIET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hilde Andersen-Gott | Chief Executive Officer | 0 companies |
| Elisabeth Haug | Chief Executive Officer | 0 companies |
| Nils Andreas Foldal | Deputy Member | 0 companies |
| Marianne Kristine Arnesen Eskeland | Board of Directors | 0 companies |
| Silje Digerud | Board of Directors | 0 companies |
| Henriette Hessen | Board of Directors | 0 companies |
| Kristin Haram Førde | Board of Directors | 0 companies |
| Jonas Petter Sundberg | Chairman | 0 companies |
| Christian Jebsen | Board of Directors | 0 companies |